Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06424327 · ClinicalTrials.gov registry record
A Registry for People With Lung Cancer
A clinical trial of Lung Cancer and Lung Cancer Stage I, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 600
- Enrollment target
- 15
- Study locations
NCT06424327: Recruiting study of Lung Cancer and Lung Cancer Stage I, sponsored by Memorial Sloan Kettering Cancer Center.
NCT06424327 is a study of Lung Cancer and Lung Cancer Stage I that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 600 participants, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (36% lower). The trial reports 15 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06424327, a study of Lung Cancer and Lung Cancer Stage I, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 15
- Study locations
Study Summary
Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.
Primary Outcome
DFS is measured from the date of surgery to the date of recurrence or death
Conditions Studied
Interventions
- OTHER Patient-Reported Outcomes Measurement Information System
Study Locations (15)
New York
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activities) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) - Montvale
Illinois
- Rush University Medical Center (Data collection only) - Chicago
- Endeavor Health - Evanston
Pennsylvania
- Thomas Jefferson University Hospital (Data Collection Only) - Philadelphia
- ALLEGHENY HEALTH NETWORK (Data Collection Only) - Pittsburgh
Michigan
- University of Michigan (Data Collection Only) - Ann Arbor
Texas
- MD Anderson Cancer Center (Data Collection Only) - Houston
Ontario
- University Health Network (Data Collection Only) - Toronto
Quebec
- Centre Hospitalier de l'Université de Montreal (Data Collection Only) - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-05-15 |
| Est. Completion | 2029-05-15 |
What NCT06424327 shows while recruiting
NCT06424327 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (36% lower).
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Patient-Reported Outcomes Measurement Information System is the first listed.
NCT06424327 lists 15 locations in 8 states (New York, New Jersey, Illinois).
Frequently Asked Questions
What is clinical trial NCT06424327 about?
NCT06424327 is a clinical study titled "A Registry for People With Lung Cancer". Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.
What is the current status of trial NCT06424327?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2024-05-15. Estimated completion is 2029-05-15.
What conditions does trial NCT06424327 study?
This clinical trial studies the following conditions: Lung Cancer, Lung Cancer Stage I.
What interventions are being tested in trial NCT06424327?
The interventions under investigation include: Patient-Reported Outcomes Measurement Information System (OTHER).
Who is sponsoring clinical trial NCT06424327?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06424327 being conducted?
This trial has 15 study locations across Illinois, Michigan, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06424327's enrollment target sits among peer trials
600 64th of 409 higher than 345 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI